ASXL1 gene alterations in patients with isolated 20q deletion
Jazyk angličtina Země Slovensko Médium electronic
Typ dokumentu časopisecké články
PubMed
30868899
DOI
10.4149/neo_2018_181010n754
PII: 181010N754
Knihovny.cz E-zdroje
- MeSH
- chromozomální delece * MeSH
- cytogenetické vyšetření MeSH
- lidé MeSH
- lidské chromozomy, pár 20 genetika MeSH
- myelodysplastické syndromy genetika MeSH
- represorové proteiny genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- ASXL1 protein, human MeSH Prohlížeč
- represorové proteiny MeSH
Deletion 20q is a recurrent abnormality in myeloid malignancies. In our previous study, we identified fusion of the additional sex combs-like 1 (ASXL1) and teashirt zinc finger homeobox 2 genes in a patient with myelodysplastic syndrome. The objective of this study was to determine the frequency of ASXL1 breakpoints in a cohort of 36 patients with deletion 20q as the sole cytogenetic aberration. A combination of molecular cytogenetic methods was used to confirm ASXL1 gene alterations in 19 of the 36 patients, and the determination of ASXL1 gene changes in patients with deletion 20q revealed clinical and prognostic impacts.
Clinical Department Institute of Hematology and Blood Transfusion Prague Czech Republic
Department of Cytogenetics Institute of Hematology and Blood Transfusion Prague Czech Republic
Citace poskytuje Crossref.org